Stage 3 Knee Arthritis: What to Know About CARTISTEM®, a Cartilage Treatment Approved in Korea and Now in U.S. Trials

Source: International Business Times

A Seoul orthopedic surgeon explains who may be considered, what the treatment involves and how American patients can ask questions in English Steve Jones SEOUL, South Korea - For many Americans with knee osteoarthritis, the conversation eventually turns to knee replacement. But some people with moderate-to-advanced arthritis, often called stage 3, still have knees that may be worth a closer look first. One option they may read about is CARTISTEM®, a cell-based cartilage treatment approved in South Korea since 2012 and now being studied in the United States.